Fluorine in PDB 7sea: Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak
Protein crystallography data
The structure of Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak, PDB code: 7sea
was solved by
Y.Shi,
I.M.El-Deeb,
V.Masic,
L.Hartley-Tassell,
A.Maggioni,
M.Vonitzstein,
T.Ve,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
45.27 /
1.91
|
Space group
|
C 2 2 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
69.131,
138.651,
66.426,
90,
90,
90
|
R / Rfree (%)
|
19.6 /
22.9
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak
(pdb code 7sea). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the
Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak, PDB code: 7sea:
Jump to Fluorine binding site number:
1;
2;
3;
Fluorine binding site 1 out
of 3 in 7sea
Go back to
Fluorine Binding Sites List in 7sea
Fluorine binding site 1 out
of 3 in the Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F407
b:46.5
occ:1.00
|
F
|
A:8XF407
|
0.0
|
46.5
|
1.0
|
C
|
A:8XF407
|
1.3
|
51.2
|
1.0
|
F2
|
A:8XF407
|
2.1
|
53.0
|
1.0
|
F1
|
A:8XF407
|
2.1
|
56.5
|
1.0
|
C1
|
A:8XF407
|
2.4
|
49.2
|
1.0
|
N2
|
A:8XF407
|
2.7
|
41.8
|
1.0
|
OD1
|
A:ASP216
|
2.7
|
30.2
|
1.0
|
HG3
|
A:ARG218
|
2.8
|
42.9
|
1.0
|
H
|
A:ALA217
|
2.9
|
25.5
|
1.0
|
H
|
A:ARG218
|
3.1
|
31.4
|
1.0
|
HB3
|
A:ALA217
|
3.1
|
29.9
|
1.0
|
HD13
|
A:ILE245
|
3.2
|
38.6
|
1.0
|
N
|
A:ALA217
|
3.4
|
21.2
|
1.0
|
C2
|
A:8XF407
|
3.6
|
47.0
|
1.0
|
N
|
A:ARG218
|
3.7
|
26.1
|
1.0
|
HH11
|
A:ARG218
|
3.7
|
56.0
|
1.0
|
HA
|
A:ASP216
|
3.8
|
31.6
|
1.0
|
CG
|
A:ASP216
|
3.8
|
30.6
|
1.0
|
CG
|
A:ARG218
|
3.8
|
35.8
|
1.0
|
NH1
|
A:ARG218
|
3.9
|
46.7
|
1.0
|
CB
|
A:ALA217
|
3.9
|
24.9
|
1.0
|
H
|
A:8XF407
|
4.0
|
56.4
|
1.0
|
CA
|
A:ALA217
|
4.0
|
24.1
|
1.0
|
C4
|
A:8XF407
|
4.0
|
37.7
|
1.0
|
HG21
|
A:ILE245
|
4.1
|
33.5
|
1.0
|
HH12
|
A:ARG218
|
4.1
|
56.0
|
1.0
|
C
|
A:ASP216
|
4.1
|
22.4
|
1.0
|
CD1
|
A:ILE245
|
4.2
|
32.2
|
1.0
|
C
|
A:ALA217
|
4.2
|
25.9
|
1.0
|
HG2
|
A:ARG218
|
4.3
|
42.9
|
1.0
|
HG3
|
A:GLN239
|
4.3
|
51.4
|
1.0
|
HB2
|
A:ARG218
|
4.3
|
43.4
|
1.0
|
HB2
|
A:ALA217
|
4.3
|
29.9
|
1.0
|
CA
|
A:ASP216
|
4.3
|
26.3
|
1.0
|
HD11
|
A:ILE245
|
4.4
|
38.6
|
1.0
|
CZ
|
A:ARG218
|
4.4
|
45.3
|
1.0
|
HD2
|
A:ARG218
|
4.4
|
50.8
|
1.0
|
CB
|
A:ARG218
|
4.4
|
36.1
|
1.0
|
OD2
|
A:ASP216
|
4.5
|
34.7
|
1.0
|
CD
|
A:ARG218
|
4.6
|
42.3
|
1.0
|
HD12
|
A:ILE245
|
4.6
|
38.6
|
1.0
|
CA
|
A:ARG218
|
4.6
|
30.4
|
1.0
|
H3
|
A:8XF407
|
4.7
|
45.2
|
1.0
|
HB1
|
A:ALA217
|
4.7
|
29.9
|
1.0
|
HG11
|
A:VAL237
|
4.7
|
34.0
|
1.0
|
CB
|
A:ASP216
|
4.7
|
29.9
|
1.0
|
NE
|
A:ARG218
|
4.7
|
46.1
|
1.0
|
C3
|
A:8XF407
|
4.7
|
43.2
|
1.0
|
HB3
|
A:PHE192
|
4.7
|
52.8
|
1.0
|
HB
|
A:VAL237
|
4.8
|
48.0
|
1.0
|
HA
|
A:ARG218
|
4.8
|
36.5
|
1.0
|
N1
|
A:8XF407
|
4.9
|
30.6
|
1.0
|
HG12
|
A:ILE245
|
4.9
|
35.3
|
1.0
|
HA
|
A:ALA217
|
4.9
|
28.9
|
1.0
|
CG2
|
A:ILE245
|
5.0
|
27.9
|
1.0
|
|
Fluorine binding site 2 out
of 3 in 7sea
Go back to
Fluorine Binding Sites List in 7sea
Fluorine binding site 2 out
of 3 in the Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F407
b:56.5
occ:1.00
|
F1
|
A:8XF407
|
0.0
|
56.5
|
1.0
|
C
|
A:8XF407
|
1.3
|
51.2
|
1.0
|
F
|
A:8XF407
|
2.1
|
46.5
|
1.0
|
F2
|
A:8XF407
|
2.1
|
53.0
|
1.0
|
C1
|
A:8XF407
|
2.4
|
49.2
|
1.0
|
N2
|
A:8XF407
|
3.1
|
41.8
|
1.0
|
CE2
|
A:PHE192
|
3.1
|
59.1
|
1.0
|
CD2
|
A:PHE192
|
3.2
|
51.6
|
1.0
|
C2
|
A:8XF407
|
3.2
|
47.0
|
1.0
|
HH12
|
A:ARG218
|
3.2
|
56.0
|
1.0
|
OD1
|
A:ASP216
|
3.3
|
30.2
|
1.0
|
H
|
A:8XF407
|
3.3
|
56.4
|
1.0
|
HH11
|
A:ARG218
|
3.3
|
56.0
|
1.0
|
HE2
|
A:PHE192
|
3.4
|
70.9
|
1.0
|
HD2
|
A:PHE192
|
3.4
|
61.9
|
1.0
|
NH1
|
A:ARG218
|
3.4
|
46.7
|
1.0
|
CZ
|
A:PHE192
|
3.5
|
55.6
|
1.0
|
CG
|
A:PHE192
|
3.6
|
48.0
|
1.0
|
CG
|
A:ASP216
|
3.8
|
30.6
|
1.0
|
HA
|
A:ASP216
|
3.8
|
31.6
|
1.0
|
CE1
|
A:PHE192
|
3.9
|
51.0
|
1.0
|
CD1
|
A:PHE192
|
3.9
|
51.5
|
1.0
|
HZ
|
A:PHE192
|
4.0
|
66.8
|
1.0
|
HB3
|
A:PHE192
|
4.0
|
52.8
|
1.0
|
H
|
A:ALA217
|
4.1
|
25.5
|
1.0
|
OD2
|
A:ASP216
|
4.1
|
34.7
|
1.0
|
C4
|
A:8XF407
|
4.2
|
37.7
|
1.0
|
HG3
|
A:ARG218
|
4.2
|
42.9
|
1.0
|
C3
|
A:8XF407
|
4.3
|
43.2
|
1.0
|
CB
|
A:PHE192
|
4.4
|
44.0
|
1.0
|
CZ
|
A:ARG218
|
4.4
|
45.3
|
1.0
|
HE1
|
A:PHE192
|
4.5
|
61.3
|
1.0
|
HD1
|
A:PHE192
|
4.5
|
61.8
|
1.0
|
HG3
|
A:GLN239
|
4.5
|
51.4
|
1.0
|
O
|
A:HOH507
|
4.6
|
44.7
|
1.0
|
CA
|
A:ASP216
|
4.6
|
26.3
|
1.0
|
H
|
A:ARG218
|
4.6
|
31.4
|
1.0
|
CB
|
A:ASP216
|
4.7
|
29.9
|
1.0
|
HB2
|
A:PHE192
|
4.7
|
52.8
|
1.0
|
N
|
A:ALA217
|
4.7
|
21.2
|
1.0
|
N1
|
A:8XF407
|
4.7
|
30.6
|
1.0
|
HB2
|
A:ASP216
|
4.8
|
35.9
|
1.0
|
HD2
|
A:ARG218
|
4.8
|
50.8
|
1.0
|
HH22
|
A:ARG218
|
4.9
|
58.0
|
1.0
|
HD13
|
A:ILE245
|
4.9
|
38.6
|
1.0
|
H3
|
A:8XF407
|
4.9
|
45.2
|
1.0
|
|
Fluorine binding site 3 out
of 3 in 7sea
Go back to
Fluorine Binding Sites List in 7sea
Fluorine binding site 3 out
of 3 in the Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Human Fibrillarin in Complex with Compound 2 From Cocktail Soak within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F407
b:53.0
occ:1.00
|
F2
|
A:8XF407
|
0.0
|
53.0
|
1.0
|
C
|
A:8XF407
|
1.3
|
51.2
|
1.0
|
F
|
A:8XF407
|
2.1
|
46.5
|
1.0
|
F1
|
A:8XF407
|
2.1
|
56.5
|
1.0
|
C1
|
A:8XF407
|
2.4
|
49.2
|
1.0
|
HG3
|
A:GLN239
|
2.5
|
51.4
|
1.0
|
H
|
A:8XF407
|
2.6
|
56.4
|
1.0
|
C2
|
A:8XF407
|
2.8
|
47.0
|
1.0
|
CG
|
A:GLN239
|
3.3
|
42.8
|
1.0
|
HH12
|
A:ARG218
|
3.4
|
56.0
|
1.0
|
N2
|
A:8XF407
|
3.5
|
41.8
|
1.0
|
HD13
|
A:ILE245
|
3.5
|
38.6
|
1.0
|
HG2
|
A:GLN239
|
3.6
|
51.4
|
1.0
|
NH1
|
A:ARG218
|
3.6
|
46.7
|
1.0
|
CD
|
A:GLN239
|
3.6
|
47.6
|
1.0
|
HB
|
A:VAL237
|
3.7
|
48.0
|
1.0
|
HH11
|
A:ARG218
|
3.8
|
56.0
|
1.0
|
HE21
|
A:GLN239
|
3.9
|
66.4
|
1.0
|
NE2
|
A:GLN239
|
3.9
|
55.3
|
1.0
|
CZ
|
A:ARG218
|
4.0
|
45.3
|
1.0
|
HG3
|
A:ARG218
|
4.0
|
42.9
|
1.0
|
HH22
|
A:ARG218
|
4.0
|
58.0
|
1.0
|
OE1
|
A:GLN239
|
4.1
|
39.6
|
1.0
|
NH2
|
A:ARG218
|
4.1
|
48.3
|
1.0
|
HD11
|
A:ILE245
|
4.2
|
38.6
|
1.0
|
CD1
|
A:ILE245
|
4.2
|
32.2
|
1.0
|
C3
|
A:8XF407
|
4.2
|
43.2
|
1.0
|
HD12
|
A:ILE245
|
4.3
|
38.6
|
1.0
|
HE22
|
A:GLN239
|
4.4
|
66.4
|
1.0
|
OD1
|
A:ASP216
|
4.5
|
30.2
|
1.0
|
CB
|
A:GLN239
|
4.5
|
42.7
|
1.0
|
CB
|
A:VAL237
|
4.6
|
40.0
|
1.0
|
HB2
|
A:GLN239
|
4.6
|
51.2
|
1.0
|
C4
|
A:8XF407
|
4.6
|
37.7
|
1.0
|
HB3
|
A:ALA217
|
4.6
|
29.9
|
1.0
|
HG11
|
A:VAL237
|
4.6
|
34.0
|
1.0
|
CZ
|
A:PHE192
|
4.7
|
55.6
|
1.0
|
HB3
|
A:GLN239
|
4.7
|
51.2
|
1.0
|
HH21
|
A:ARG218
|
4.7
|
58.0
|
1.0
|
NE
|
A:ARG218
|
4.7
|
46.1
|
1.0
|
H
|
A:ALA217
|
4.8
|
25.5
|
1.0
|
CE2
|
A:PHE192
|
4.8
|
59.1
|
1.0
|
HZ
|
A:PHE192
|
4.8
|
66.8
|
1.0
|
HG21
|
A:VAL237
|
4.8
|
43.9
|
1.0
|
CE1
|
A:PHE192
|
4.8
|
51.0
|
1.0
|
HG12
|
A:VAL237
|
4.9
|
34.0
|
1.0
|
O
|
A:VAL237
|
4.9
|
39.2
|
1.0
|
CG
|
A:ARG218
|
4.9
|
35.8
|
1.0
|
HG21
|
A:ILE245
|
4.9
|
33.5
|
1.0
|
CG1
|
A:VAL237
|
4.9
|
28.4
|
1.0
|
N1
|
A:8XF407
|
4.9
|
30.6
|
1.0
|
|
Reference:
Y.Shi,
I.M.El-Deeb,
V.Masic,
L.Hartley-Tassell,
A.Maggioni,
M.V.Itzstein,
T.Ve.
Discovery of Cofactor Competitive Inhibitors Against the Human Methyltransferase Fibrillarin. Pharmaceuticals V. 15 2021.
ISSN: ESSN 1424-8247
PubMed: 35056083
DOI: 10.3390/PH15010026
Page generated: Fri Aug 2 12:52:34 2024
|